Amgen to terminate participation in co-development and commercialization of brodalumab

Go back to Amgen to terminate participation in co-development and commercialization of brodalumab
Amgen Inc (NASDAQ: AMGN) Delayed: 439.26 -8.02 (1.79%)
Previous Close $447.28    52 Week High $176.85 
Open $444.40    52 Week Low $133.64 
Day High $444.59    P/E 66.15 
Day Low $439.07    EPS $6.64 
Volume 2,074,504       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 3,691,379       

Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) Delayed: 19.04 +0.18 (0.95%)
Previous Close $18.86    52 Week High $18.64 
Open $18.91    52 Week Low $12.59 
Day High $19.04    P/E N/A 
Day Low $18.90    EPS $0.00 
Volume 23,587